---
schema_version: "secwatch.filing_event.v1"
accession: "0001757898-24-000017"
form_type: "8-K"
ticker: "STE"
cik: "0001757898"
company_name: "STERIS plc"
filed_at: "2024-11-06T23:59:59+00:00"
generated_at: "2026-05-30T04:41:25.087513+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# STERIS Q2 adjusted EPS $2.14, revenue $1.3B (+7%); reiterates FY2025 outlook

## Summary
- Adjusted EPS from continuing operations $2.14 vs $1.86 prior year; as-reported EPS $1.51 vs $1.20.
- Total revenue $1.3B, +7% as reported and constant currency organic growth.
- Healthcare revenue +9% to $944.2M, driven by consumables (+12%) and service (+14%); capital equipment -2%.
- AST revenue +9% to $256.7M; Life Sciences revenue -4% to $127.9M due to divestiture, organic +3%.
- FY2025 outlook reiterated: revenue growth 6.5-7.5%, adjusted EPS $9.05-$9.25, free cash flow ~$700M.

## SEC filing metadata
- accession: 0001757898-24-000017
- form_type: 8-K
- ticker: STE
- cik: 0001757898
- company_name: STERIS plc
- filed_at: 2024-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757898/000175789824000017/0001757898-24-000017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757898/000175789824000017/ste-20241106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001757898-24-000017
- JSON: https://secwatch.observer/filing/0001757898-24-000017.json
- Plain text: https://secwatch.observer/filing/0001757898-24-000017.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.